These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20876458)

  • 1. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency.
    Jalagadugula G; Mao G; Kaur G; Goldfinger LE; Dhanasekaran DN; Rao AK
    Blood; 2010 Dec; 116(26):6037-45. PubMed ID: 20876458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of PLDN (pallidin) is a mechanism for platelet dense granule deficiency in RUNX1 haplodeficiency.
    Mao GF; Goldfinger LE; Fan DC; Lambert MP; Jalagadugula G; Freishtat R; Rao AK
    J Thromb Haemost; 2017 Apr; 15(4):792-801. PubMed ID: 28075530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profiling.
    Sun L; Gorospe JR; Hoffman EP; Rao AK
    J Thromb Haemost; 2007 Jan; 5(1):146-54. PubMed ID: 17059412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency.
    Kaur G; Jalagadugula G; Mao G; Rao AK
    Blood; 2010 Apr; 115(15):3128-35. PubMed ID: 20181616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.
    Jalagadugula G; Mao G; Kaur G; Dhanasekaran DN; Rao AK
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):921-7. PubMed ID: 21252065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression.
    Bluteau D; Glembotsky AC; Raimbault A; Balayn N; Gilles L; Rameau P; Nurden P; Alessi MC; Debili N; Vainchenker W; Heller PG; Favier R; Raslova H
    Blood; 2012 Sep; 120(13):2708-18. PubMed ID: 22898599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia.
    Glembotsky AC; Sliwa D; Bluteau D; Balayn N; Marin Oyarzún CP; Raimbault A; Bordas M; Droin N; Pirozhkova I; Washington V; Goette NP; Marta RF; Favier R; Raslova H; Heller PG
    Haematologica; 2019 Jun; 104(6):1244-1255. PubMed ID: 30545930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets.
    Glembotsky AC; Bluteau D; Espasandin YR; Goette NP; Marta RF; Marin Oyarzun CP; Korin L; Lev PR; Laguens RP; Molinas FC; Raslova H; Heller PG
    J Thromb Haemost; 2014 May; 12(5):761-72. PubMed ID: 24606315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor.
    Jalagadugula G; Goldfinger LE; Mao G; Lambert MP; Rao AK
    Blood Adv; 2018 Apr; 2(7):797-806. PubMed ID: 29632235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4.
    Aneja K; Jalagadugula G; Mao G; Singh A; Rao AK
    J Thromb Haemost; 2011 Feb; 9(2):383-91. PubMed ID: 21129147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective acid hydrolase secretion in RUNX1 haplodeficiency: Evidence for a global platelet secretory defect.
    Rao AK; Poncz M
    Haemophilia; 2017 Sep; 23(5):784-792. PubMed ID: 28662545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.
    Okada Y; Watanabe M; Nakai T; Kamikawa Y; Shimizu M; Fukuhara Y; Yonekura M; Matsuura E; Hoshika Y; Nagai R; Aird WC; Doi T
    J Thromb Haemost; 2013 Sep; 11(9):1742-50. PubMed ID: 23848403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations.
    Antony-Debré I; Bluteau D; Itzykson R; Baccini V; Renneville A; Boehlen F; Morabito M; Droin N; Deswarte C; Chang Y; Leverger G; Solary E; Vainchenker W; Favier R; Raslova H
    Blood; 2012 Sep; 120(13):2719-22. PubMed ID: 22677128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Platelet Phenotype Caused by a Germline RUNX1 Variant in a CRISPR/Cas9-Generated Murine Model.
    Marín-Quílez A; García-Tuñón I; Fernández-Infante C; Hernández-Cano L; Palma-Barqueros V; Vuelta E; Sánchez-Martín M; González-Porras JR; Guerrero C; Benito R; Rivera J; Hernández-Rivas JM; Bastida JM
    Thromb Haemost; 2021 Sep; 121(9):1193-1205. PubMed ID: 33626581
    [No Abstract]   [Full Text] [Related]  

  • 15. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
    Heller PG; Glembotsky AC; Gandhi MJ; Cummings CL; Pirola CJ; Marta RF; Kornblihtt LI; Drachman JG; Molinas FC
    Blood; 2005 Jun; 105(12):4664-70. PubMed ID: 15741216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9.
    Gilles L; Bluteau D; Boukour S; Chang Y; Zhang Y; Robert T; Dessen P; Debili N; Bernard OA; Vainchenker W; Raslova H
    Blood; 2009 Nov; 114(19):4221-32. PubMed ID: 19724058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered platelet-megakaryocyte endocytosis and trafficking of albumin and fibrinogen in RUNX1 haplodeficiency.
    Del Carpio-Cano F; Mao G; Goldfinger LE; Wurtzel J; Guan L; Alam MA; Lee K; Poncz M; Rao AK
    Blood Adv; 2024 Apr; 8(7):1699-1714. PubMed ID: 38330198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription Factor RUNX1 Regulates Platelet
    Mao G; Songdej N; Voora D; Goldfinger LE; Del Carpio-Cano FE; Myers RA; Rao AK
    Circulation; 2017 Sep; 136(10):927-939. PubMed ID: 28676520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLI1 is associated with regulation of DNA methylation and megakaryocytic differentiation in FPDMM caused by a RUNX1 transactivation domain mutation.
    Tanaka Y; Nakanishi Y; Furuhata E; Nakada KI; Maruyama R; Suzuki H; Suzuki T
    Sci Rep; 2024 Jun; 14(1):14080. PubMed ID: 38890442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.
    Antony-Debré I; Manchev VT; Balayn N; Bluteau D; Tomowiak C; Legrand C; Langlois T; Bawa O; Tosca L; Tachdjian G; Leheup B; Debili N; Plo I; Mills JA; French DL; Weiss MJ; Solary E; Favier R; Vainchenker W; Raslova H
    Blood; 2015 Feb; 125(6):930-40. PubMed ID: 25490895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.